I guess I’ll just say it. No I believe Merck is
Post# of 155577
Not sure why they haven’t just said it yet.
https://www.biopharmadive.com/news/merck-deal...is/706309/
“The company is also developing combination formulations that pair Keytruda with other immunotherapies aimed at different cellular targets.“
As I had to point out once already today. Leronlimab is an immunotherapy!
Merck I’ll take 115 billon yesterday let’s get this show on the road.
Oh wait you said 15 billon. I guess we shall see.


CytoDyn Inc (CYDY) Stock Research Links
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com